Ropes & Gray has advised AbbVie on the transaction, and Cooley has advised Capstan TherapeuticsAbbVie has announced the acquisition of Capstan Therapeutics in a transaction valued…
AbbVie Acquires Capstan Therapeutics in $2.1 Billion Deal to Expand Immunotherapy Portfolio
